Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes

scientific article published on 30 October 2009

Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1013536820
P356DOI10.1038/HR.2009.176
P698PubMed publication ID19876064
P5875ResearchGate publication ID38054512

P50authorLuis J. FuentesQ39574724
P2093author name stringAndrés Carrillo
Carmen Antúnez
Ginés Ortega
Guillermo Campoy
José M García Santos
Juan B Vidal
Julia García-Sevilla
Martirio Antequera
Silvia Torres del Río
P2860cites workBlood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaQ24246379
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Magnetic resonance spectroscopy in AD.Q30640894
Neuroimaging in Alzheimer disease: an evidence-based reviewQ30844900
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experienceQ30983673
Cerebral microbleeds: a guide to detection and interpretationQ33401999
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure ResearchQ34768060
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentQ35868499
Blood pressure reduction for vascular risk: is there a price to be paid?Q36110348
1H magnetic resonance spectroscopy in dementiaQ37150637
Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertensionQ37239502
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS studyQ37407266
The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.Q40393281
A new rating scale for age-related white matter changes applicable to MRI and CT.Q42505285
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability studyQ42525500
A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsyQ44117266
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's diseaseQ44169486
Reproducibility of 1H-MRS measurements in schizophrenic patients.Q44605759
Serial proton magnetic resonance spectroscopy of the brain in children undergoing cardiac surgery.Q44633275
N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderlyQ46241199
Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatmentQ46316754
Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease.Q46788178
Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's diseaseQ46792185
Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratioQ46977572
Association of ambulatory blood pressure with ischemic brain injuryQ48219934
Cognitive impairment and white matter damage in hypertension: a pilot study.Q48922227
Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changesQ49161285
Clinical validity of the 'mini-mental state' for Spanish speaking communitiesQ52017691
Prevalence and control of arterial hypertension in the south-east of Spain: a radical but still insufficient improvementQ57252121
The Association Between Blood Pressure, Hypertension, and Cerebral White Matter LesionsQ57782031
Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjectsQ57813839
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarctsQ71670103
P433issue1
P304page(s)67-75
P577publication date2009-10-30
P1433published inHypertension ResearchQ15762136
P1476titlePosterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes
P478volume33

Reverse relations

cites work (P2860)
Q50655715Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.
Q50771406Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSC
Q36961709Dyslipidemia links obesity to early cerebral neurochemical alterations
Q42824364Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.
Q36209987Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations
Q46485838Is there a specific pattern of attention deficit in mild cognitive impairment with subcortical vascular features? Evidence from the Attention Network Test

Search more.